Healthcare Dec 02, 2021 09:54 AM (GMT+8) · EqualOcean
GlaxoSmithKline said that Philip Dormitzer, who previously served as the chief scientific officer of virus vaccine at Pfizer, would join GlaxoSmithKline as the head of the company's global vaccine R & D department. GlaxoSmithKline said Friday would be Dormitzer's first day. GlaxoSmithKline is one of the world's largest vaccine manufacturers, but it lags behind other pharmaceutical companies in the competition to develop a new crown vaccine. GlaxoSmithKline is waiting for the results of a large clinical trial of a vaccine jointly developed by GlaxoSmithKline and Sanofi group.